Back to search
Pulmonary Non-tuberculous Mycobacterial Lung Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Non-tuberculous Mycobacterial Lung Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Non-tuberculous Mycobacterial Lung Disease trials you may qualify forThis study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment…
The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.
This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It…
The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and func…
This is a prospective observational study using whole genome sequencing (WGS) to investigate whether new strains (other than the initially identified strain(s))…
In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progres…
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
Healthy volunteers and patients with diseases that involve problems clearing mucus from the lungs will be examined and tested to better understand the reasons f…
Background: \- Pulmonary nontuberculous mycobacterial infection is a respiratory infection that is sometimes difficult to diagnose. Proper diagnosis depends on…